The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Cited by (1,044)

Items 801–900 of 1,044

1. Novel therapeutic approaches to post-infarction remodelling
   Daniela Fraccarollo, Paolo Galuppo, Johann K Bauersachs · 2012 · Cardiovascular Research
2. Aldosterone Promotes Vascular Remodeling by Direct Effects on Smooth Muscle Cell Mineralocorticoid Receptors
   Dafina Pruthi, Amy McCurley, Mark A. Aronovitz, Carol Galayda, S. Ananth Karumanchi, Iris Zamir Jaffe · 2013 · Arteriosclerosis Thrombosis and Vascular Biology
3. A randomized controlled study of finerenone versus placebo in Japanese patients with type 2 diabetes mellitus and diabetic nephropathy
   Shigehiro Katayama, Daishiro Yamada, Mikihiro Nakayama, Takashi Yamada, Masafumi Myoishi, Masaharu C. Kato, Christina Nowack, Peter Kolkhof, Yoshimitsu Yamasaki · 2016 · Journal of Diabetes and its Complications
4. Heart Failure Oral Therapies at Discharge are Associated with Better Outcome in Acute Heart Failure: A Propensity-Score Matched Study
   Étienne Gayat, Mattia Arrigo, Simona Littnerová, Naoki Sato, Jiří Pařenica, Shiro Ishihara, Jindřich Špinar, Christian Eugen Mueller, Veli‐Pekka Harjola, Johan P.E. Lassus et al. · 2014 · European Journal of Heart Failure
5. Treatment of Hypertension in Patients With Coronary Artery Disease
   Clive Rosendorff, Daniel T. Lackland, Matthew Allison, Wilbert S. Aronow, Henry R. Black, Roger Scott Blumenthal, Christopher Paul Cannon, James A. de Lemos, W.J. Elliott, Laura Findeiss et al. · 2015 · Journal of the American College of Cardiology
6. Aldosterone Receptor Antagonism Induces Reverse Remodeling When Added to Angiotensin Receptor Blockade in Chronic Heart Failure
   Anna Kin-Yin Chan, John Elsby Sanderson, Tian Wang, Wynnie W. M. Lam, Gabriel Wai‐Kwok Yip, Mei Wang, Yat‐Yin Lam, Yan Zhang, Leata Y.C. Yeung, Eugene Brian Wu et al. · 2007 · Journal of the American College of Cardiology
7. A Randomized Trial of Telenursing to Reduce Hospitalization for Heart Failure: Patient-Centered Outcomes and Nursing Indicators
   Anthony F. Jerant, Rahman S. Azari, Carmen Martinez, Thomas S. Nesbitt · 2003 · Home Health Care Services Quarterly
8. Origin of Aldosterone in the Rat Heart
   Elise P. Gómez-Sánchez, Naveed Ahmad, Damián G. Romero, Celso E. Gómez-Sánchez · 2004 · Endocrinology
9. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition
   R. M. A. van de Wal, H.W.M. Plokker, Dirk J. A. Lok, Frans Boomsma, Frans A. L. van der Horst, Dirk J van Veldhuisen, Wiek H. van Gilst, A.A. Voors · 2005 · International Journal of Cardiology
10. Clinical Features and Contemporary Management of Patients with Low and Preserved Ejection Fraction Heart Failure: Baseline Characteristics of Patients in the Candesartan in Heart failure—Assessment of Reduction in Mortality and Morbidity (CHARM) Programme
    John J.V. McMurray, Jan Östergren, Michael Pfeffer, Karl B Swedberg, Christopher Bull Granger, Salim Yusuf, Peter Held, Eric L. Michelson, Bertil Olofsson · 2003 · European Journal of Heart Failure
11. Mineralocorticoid Receptor-Associated Hypertension and Its Organ Damage: Clinical Relevance for Resistant Hypertension
    Hirotaka Shibata, H. Itoh · 2012 · American Journal of Hypertension
12. The Mineralocorticoid Receptor Promotes Fibrotic Remodeling in Atrial Fibrillation
    Daniel Lavall, Christian Selzer, Pia Schuster, Matthias Lenski, Oliver Adam, Hans‐Joachim Schäfers, Michael Böhm, Ulrich Laufs · 2014 · Journal of Biological Chemistry
13. Pathophysiology of Cardiorenal Syndrome Type 2 in Stable Chronic Heart Failure: Workgroup Statements from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)
    Dinna N. Cruz, Kai Martin Schmidt-Ott, Giorgio Vescovo, Andrew A. House, John A. Kellum, Claudio Ronco, Peter Andrew McCullough, for the Acute Dialysis Quality Initiative (ADQI) Consensus Group · 2013 · Contributions to nephrology
14. Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure
    Pasquale Santangeli, Jesus Eduardo Rame, Edo Y. Birati, Francis E. Marchlinski · 2017 · Journal of the American College of Cardiology
15. Mineralocorticoid Receptor and Cardiovascular Disease
    Mathieu Buonafine, Benjamin Bonnard, Frédéric Jaisser · 2018 · American Journal of Hypertension
16. Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
    Theresa A. McDonagh, Marco Metra, Marianna Adamo, Roy S. Gardner, Andreas Baumbach, Michael Böhm, Haran Burri, Javed Butler, Jelena Čelutkienė, Ovidiu Dragomir Chioncel et al. · 2022 · Revista Española de Cardiología
17. Dilated Cardiomyopathy
    Neal K. Lakdawala, Jeffery R. Winterfield, Birgit Funke · 2012 · Circulation Arrhythmia and Electrophysiology
18. Aldosterone Induces Superoxide Generation via Rac1 Activation in Endothelial Cells
    Fumiko Iwashima, Takanobu Yoshimoto, Isao Minami, Maya Sakurada, Yuki Hirono, Yukio Hirata · 2007 · Endocrinology
19. Cardiac Steroidogenesis in the Normal and Failing Heart
    Morag J. Young, Colin D. Clyne, Tim James Cole, John W. Funder · 2001 · The Journal of Clinical Endocrinology & Metabolism
20. Effect of Spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy
    Félix José Alvarez Ramires, Antônio de Pádua Mansur, Otávio Rizzi Coelho, Mario Maranhão, Cesar José Gruppi, Charles Mady, José Antônio Franchini Ramires · 2000 · The American Journal of Cardiology
21. Aldosterone, mineralocorticoid receptor, and heart failure
    Smail Messaoudi, Fériel Azibani, Claude Delcayre, Frédéric Jaisser · 2011 · Molecular and Cellular Endocrinology
22. CKD and Sudden Cardiac Death
    Isaac R. Whitman, Harold I. Feldman, Rajat Deo · 2012 · Journal of the American Society of Nephrology
23. Chronic Heart Failure
    Ryan P. Morrissey, Lawrence S.C. Czer, Prediman K. Shah · 2011 · American Journal of Cardiovascular Drugs
24. Extra‐adrenal production of corticosteroids
    Eleanor Davies, Scott Mackay MacKenzie · 2003 · Clinical and Experimental Pharmacology and Physiology
25. The Hypolipidemic Natural Product Guggulsterone Is a Promiscuous Steroid Receptor Ligand
    Thomas P. Burris, Chahrzad Montrose, Keith A. Houck, Harold E. Osborne, Wayne P. Bocchinfuso, Benjamin C. Yaden, Christine C. Cheng, Richard W. Zink, Robert J. Barr, Christoper D. Hepler et al. · 2004 · Molecular Pharmacology
26. New York Heart Association functional class predicts exercise parameters in the current era
    Stuart D. Russell, Matthew A. Saval, Jennifer L. Robbins, Myrvin Ellestad, Stephen S. Gottlieb, Eileen Mary Handberg, Yi Zhou, Bleakley Chandler · 2009 · American Heart Journal
27. TRV120027, a Novel β-Arrestin Biased Ligand at the Angiotensin II Type I Receptor, Unloads the Heart and Maintains Renal Function When Added to Furosemide in Experimental Heart Failure
    Guido Boerrigter, David G. Soergel, Jonathan D. Violin, Michael W. Lark, John C. Jr Burnett · 2012 · Circulation Heart Failure
28. Changing Characteristics and Mode of Death Associated With Chronic Heart Failure Caused by Left Ventricular Systolic Dysfunction
    Richard M. Cubbon, Chris P Gale, Lorraine C. Kearney, Clyde B. Schechter, W Paul Brooksby, Jim Nolan, Keith A.A. Fox, Adil Rajwani, Wazir Baig, David Groves et al. · 2011 · Circulation Heart Failure
29. Heart Failure in Women
    Biykem Bozkurt, Shaden Z. Khalaf · 2017 · Methodist DeBakey Cardiovascular Journal
30. Increased Expression of Mineralocorticoid Effector Mechanisms in Kidney Biopsies of Patients With Heavy Proteinuria
    Marcus O. Quinkler, Daniel Zehnder, Kevin S. Eardley, Julia Lepenies, Alexander J. Howie, Susan V. Hughes, Paul Cockwell, Martin Hewison, Paul M. Stewart · 2005 · Circulation
31. Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. The OSCUR study
    Paolo Bellotti · 2001 · European Heart Journal
32. Relations of Serum Aldosterone to Cardiac Structure
    Ramachandran Srini Vasan, Jane C. Evans, Emelia J. Benjamin, Daniel A Levy, Martin G. Larson, Johan Sundström, Joanne M. Murabito, Flora Sam, Wilson S. Colucci, Peter W.F. Wilson · 2004 · Hypertension
33. Targeting Fibrosis for the Treatment of Heart Failure: A Role for Transforming Growth Factor‐β
    Amanda J. Edgley, Henry Krum, Darren J. Kelly · 2010 · Cardiovascular Therapeutics
34. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease
    Andreas Tomaschitz, Eberhard Ritz, Burkert Mathias Pieske, Astrid Fahrleitner‐Pammer, Katharina Kienreich, Jörg H. Horina, Christiane Drechsler, Winfried März, Michael Ofner, Thomas Rudolf Pieber et al. · 2012 · Cardiovascular Research
35. Mineralocorticoid Receptor Activation Promotes Vascular Cell Calcification
    Iris Zamir Jaffe, Yin Tintut, Brenna G. Newfell, Linda L. Demer, Michael E. Mendelsohn · 2007 · Arteriosclerosis Thrombosis and Vascular Biology
36. Exercise Oscillatory Ventilation May Predict Sudden Cardiac Death in Heart Failure Patients
    Marco Guazzi, Rosa Raimondo, Marco Vicenzi, Ross A Arena, Chiara Proserpio, Simona Sarzi Braga, Roberto F.E. Pedretti · 2007 · Journal of the American College of Cardiology
37. Practical Recommendations for the Use of ACE Inhibitors, Beta-Blockers, Aldosterone Antagonists and Angiotensin Receptor Blockers in Heart Failure: Putting Guidelines into Practice
    John J.V. McMurray, Alain Cohen Solal, Rainer Dietz, Eric J. Eichhorn, Leif Erhardt, Richard F. Hobbs, Henry Krum, Aldo Pietro Maggioni, Robert Samuel McKelvie, Ileana L. Piña et al. · 2005 · European Journal of Heart Failure
38. Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease
    Atsushi Sato, Kenshi Hayashi, Takao Saruta · 2005 · American Journal of Hypertension
39. Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes
    Nathalie Lalevée, M. C. Rebsamen, Stéphanie Barrère‐Lemaire, Emeline Perrier‐Groult, Joël Nargeot, Jean‐Pierre Bénitah, Michel Florian Rossier · 2005 · Cardiovascular Research
40. Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1c levels in patients with chronic heart failure
    Masayuki Yamaji, Takayoshi Tsutamoto, Chiho Kawahara, Keizo Nishiyama, Takashi Yamamoto, Masanori Fujii, Minoru Horie · 2010 · American Heart Journal
41. Aldosterone Breakthrough During Angiotensin II Receptor Antagonist Therapy in Stroke-Prone Spontaneously Hypertensive Rats
    Mitsuhide Naruse, Akiyo Tanabe, Atsuhisa Sato, Sachiko Takagi, Ken Tsuchiya, Toshihiro Imaki, Kazue Takano · 2002 · Hypertension
42. New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone
    Norma Araceli Bobadilla, Gerardo Gamba · 2007 · American Journal of Physiology-Renal Physiology
43. Is the Gap Between Guidelines and Clinical Practice in Heart Failure Treatment Being Filled? Insights from the IMPACT RECO Survey
    Pascal de Groote, Richard Isnard, Patrick Assyag, Pierre Clerson, Alain Ducardonnet, Michel Galinier, Guillaume Jondeau, Irina Leurs, Jean-François Thébaut, Michel Komajda N · 2007 · European Journal of Heart Failure
44. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
    Nicole Martin, Karthick Manoharan, James Thomas, Ceri Davies, R Thomas Lumbers · 2018 · Cochrane Database of Systematic Reviews
45. Effect of Eplerenone, a Selective Aldosterone Blocker, on Blood Pressure, Serum and Macrophage Oxidative Stress, and Atherosclerosis in Apolipoprotein E–Deficient Mice
    Shlomo Keidar, Tony Hayek, Marielle Kaplan, Elsa Pavlotzky, Shadi Hamoud, Raymond Coleman, Michael Aviram · 2003 · Journal of Cardiovascular Pharmacology
46. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
    Liviu Klein, Christopher M. O’Connor, Wendy A. Gattis, Manuela Zampino, Leonardo De Luca, Antonio Vitarelli, Francesco Fedele, Mihai Gheorghiade · 2003 · The American Journal of Cardiology
47. Aldosterone and Myocardial Fibrosis in Heart Failure
    Christian G. Brilla · 2000 · Herz
48. Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'?
    Gregory Y.H. Lip · 2000 · European Heart Journal
49. Aldosteronism and Peripheral Blood Mononuclear Cell Activation
    Robert A. Ahokas, Kenneth J. Warrington, Ivan Gerling, Yao Sun, Linus A. Wodi, Paula A. Herring, Li Lu, Syamal K. Bhattacharya, Arnold E. Postlethwaite, Karl T. Weber · 2003 · Circulation Research
50. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives
    Andreas Kjær, Birger Hesse · 2001 · Clinical Physiology
51. Aldosterone as a Mediator in Cardiovascular Injury
    Charles T. Stier, Praveen N. Chander, Ricardo Rocha · 2002 · Cardiology in Review
52. Free radical production and angiotensin
    Gunter Wolf · 2000 · Current Hypertension Reports
53. Aldosterone and Spironolactone in Heart Failure
    Karl T. Weber · 1999 · New England Journal of Medicine
54. The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
    Victor J. Dzau, Elliott Marshall Antman, Henry Richard Black, David L. Hayes, JoAnn E. Manson, Jorge Plutzky, Jeffrey J. Popma, William G. Stevenson · 2006 · Circulation
55. Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD
    Arjun D. Sinha, Rajiv Agarwal · 2018 · Clinical Journal of the American Society of Nephrology
56. Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology
    Stefano Bianchi, Filippo Aucella, Luca De Nicola, Simonetta Genovesi, Ernesto Paoletti, Giuseppe Regolisti · 2019 · Journal of Nephrology
57. Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone
    Paul G.H. Mulder, Virginie Mellin, Julie Favre, M. Vercauteren, Isabelle Rémy‐Jouet, Christelle Monteil, Vincent J. Richard, Sylvanie Renet, J. P. Henry, A. Y. Jeng et al. · 2008 · European Heart Journal
58. Macrophage Mineralocorticoid Receptor Signaling Plays a Key Role in Aldosterone-Independent Cardiac Fibrosis
    Laura A. Bienvenu, James Morgan, Amanda J. Rickard, Greg H. Tesch, Greg A. Cranston, Elizabeth K. Fletcher, Lea M.D. Delbridge, Morag J. Young · 2012 · Endocrinology
59. Key inflammatory mechanisms underlying heart failure
    Christian Riehle, Johann K Bauersachs · 2019 · Herz
60. Cardiorenal Syndrome
    Claudio Ronco, Luca Di Lullo · 2014 · Heart Failure Clinics
61. The Clinical Implications of Aldosterone Escape in Congestive Heart Failure
    Allan D. Struthers · 2004 · European Journal of Heart Failure
62. Congenital heart disease: the original heart failure syndrome
    Aidan P. Bolger · 2003 · European Heart Journal
63. Acute decompensated heart failure: contemporary medical management.
    Susan M Joseph, Ari Michael Cedars, Gregory Alan Ewald, Edward M. Geltman, Douglas L. Mann · 2009 · PubMed Central
64. Role of T-type Ca2+ channels in the heart
    Guy Vassort, Karel Talavera, Julio L. Alvarez · 2006 · Cell Calcium
65. Cardioprotective function of cardiac macrophages
    Katsuhito Fujiu, Jingjing Wang, R Nagai · 2014 · Cardiovascular Research
66. Pathogenesis of Cardiovascular Disease in Diabetes
    Andrea V Haas, Marie Elizabeth McDonnell · 2018 · Endocrinology and Metabolism Clinics of North America
67. Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects
    Patrick Rossignol, Joël Ménard, Renaud Fay, Finn Gustafsson, Bertram Pitt, Faiez M. Zannad · 2011 · Journal of the American College of Cardiology
68. Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy
    Akira Sato · 2003 · American Journal of Hypertension
69. The role of endothelins and their receptors in heart failure
    Daniela Giannessi, Silvia Del Ry, R.L. Vitale · 2001 · Pharmacological Research
70. Heart failure and the brain: new perspectives
    Robert B. Felder, Joseph Francis, Zhihua Zhang, Shun‐Guang Wei, Robert M. Weiss, Alan Kim Johnson · 2003 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
71. ALDOSTERONE
    Rachell E. Booth, John P. Johnson, James D. Stockand · 2002 · AJP Advances in Physiology Education
72. New aspects of rapid aldosterone signaling
    Claudia Großmann, Michael Gekle · 2009 · Molecular and Cellular Endocrinology
73. Análisis de la disminución de la mortalidad por enfermedad coronaria en una población mediterránea: España 1988-2005
    Gemma Flores‐Mateo, María Grau, Martín O’Flaherty, Rafel Ramos, Roberto Elosúa, Concepción Violán, Miquel Quesada, Ruth Martí‐Lluch, Joan Sala, Jaume Marrugat et al. · 2011 · Revista Española de Cardiología
74. Using medications appropriately in older adults.
    Cynthia M Willlams · 2002 · PubMed
75. Novel therapeutic targets for hypertension
    Ludovít Paulis, Thomas Unger · 2010 · Nature Reviews Cardiology
76. Cardiomyocyte Mineralocorticoid Receptors Are Essential for Deoxycorticosterone/Salt-Mediated Inflammation and Cardiac Fibrosis
    Amanda J. Rickard, James Morgan, Laura A. Bienvenu, Elizabeth K. Fletcher, Greg A. Cranston, Jimmy Shen, Melissa E. Reichelt, Lea M.D. Delbridge, Morag J. Young · 2012 · Hypertension
77. Essential role of ICAM-1 in aldosterone-induced atherosclerosis
    Vincenzo Marzolla, Andrea Armani, Caterina Mammi, M. Elizabeth Moss, Vittoria Pagliarini, Laura Pontecorvo, Antonella Antelmi, Andrea Fabbri, Giuseppe M.C. Rosano, Iris Zamir Jaffe et al. · 2017 · International Journal of Cardiology
78. Sodium Retention in Heart Failure and Cirrhosis
    Shweta Bansal, JoAnn M. Lindenfeld, Robert W. Schrier · 2009 · Circulation Heart Failure
79. Epidemiology, Pathophysiology, Prognosis, and Treatment of Systolic and Diastolic Heart Failure
    Wilbert S. Aronow · 2006 · Cardiology in Review
80. Long-term renal consequences of hypertension for normal and diseased kidneys
    ANIL K. BIDANI, Karen A. Griffin · 2002 · Current Opinion in Nephrology & Hypertension
81. Spironolactone impairs endothelial function and heart rate variability in patients with Type 2 diabetes
    Justine Ina Davies, Margaret M. Band, A. D. Morris, Allan D. Struthers · 2004 · Diabetologia
82. RALES, EPHESUS and redox
    John W. Funder · 2005 · The Journal of Steroid Biochemistry and Molecular Biology
83. Anticancer Agents and Cardiotoxicity
    Raymond Chee Hui Ng, Nathan Better, Michael D. Green · 2006 · Seminars in Oncology
84. Current Evidence on Treatment of Patients With Chronic Systolic Heart Failure and Renal Insufficiency
    Damman, Kevin, Tang, W.H. Wilson, Felker, G. Michael, Lassus, Johan, Zannad, Faiez, Krum, Henry, McMurray, John J.V. · 2014 · Journal of the American College of Cardiology
85. Worsening Renal Function During Renin–Angiotensin–Aldosterone System Inhibitor Initiation and Long-Term Outcomes in Patients with Left Ventricular Systolic Dysfunction
    Hannah Clark, Henry Krum, Ingrid Hopper · 2013 · European Journal of Heart Failure
86. Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy
    Naoki Okumura, Pardeep S. Jhund, Jianjian Gong, Martin P. Lefkowitz, Adel R. Rizkala, Jean Lucien Rouleau, Victor Chengwei Shi, Karl B Swedberg, Michael R. Zile, Scott David Solomon et al. · 2016 · Circulation Heart Failure
87. Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA ( Vericiguat Global Study in Subjects with HFrEF ) trial
    Adriaan A. Voors, Hillary S. Mulder, Eugene B. Reyes, Martín Cowie, Johan P.E. Lassus, Adrian F. Hernandez, Justin Adrian Ezekowitz, Javed Butler, Christopher M. O’Connor, Joerg Koglin et al. · 2021 · European Journal of Heart Failure
88. Cortisol metabolism in hypertension
    Fabian Hammer, Paul M. Stewart · 2006 · Best Practice & Research Clinical Endocrinology & Metabolism
89. The Challenge of Sudden Death in Dialysis Patients
    Eberhard Ritz, Christoph Wanner · 2008 · Clinical Journal of the American Society of Nephrology
90. Mechanisms of Hypertension
    E. Marie Freel, John Connell · 2004 · Journal of the American Society of Nephrology
91. Phosphatase-Resistant Gap Junctions Inhibit Pathological Remodeling and Prevent Arrhythmias
    Benjamin F. Remo, Jiaxiang Qu, Frank Volpicelli, Steven Giovannone, Daniel Shin, Joshua M. Lader, Fangyu Liu, Jie Zhang, Danielle Lent, Gregory E. Morley et al. · 2011 · Circulation Research
92. Therapeutic Advances in Diabetic Nephropathy
    Hanny Sawaf, George Thomas, Jonathan J. Taliercio, Georges Nakhoul, Tushar J. Vachharajani, Ali Mehdi · 2022 · Journal of Clinical Medicine
93. How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?
    Morten Svensson, Finn Gustafsson, Søren Galatius, Per Rossen Hildebrandt, Dan Atar · 2004 · Journal of Cardiac Failure
94. Aldosterone Nongenomically Produces NADPH Oxidase−Dependent Reactive Oxygen Species and Induces Myocyte Apoptosis
    Hironori Hayashi, Miyuki Kobara, Masaki ABE, Nana Tanaka, Eri Gouda, Hiroe Toba, Hiroyuki Yamada, Tetsuya Tatsumi, Tetsuo Nakata, Hiroaki Matsubara · 2008 · Hypertension Research
95. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases
    Eike Wrenger, Regina Müller, Michael Moesenthin, Tobias Welte, Jürgen C Frölich, Klaus H Neumann · 2003 · BMJ
96. Heart rate variability - a therapeutic target?
    Helen Routledge, Saqib Chowdhary, John Townend · 2002 · Journal of Clinical Pharmacy and Therapeutics
97. Rapid Inhibition of Vasoconstriction in Renal Afferent Arterioles by Aldosterone
    Torben R. Uhrenholt, Jeppe Schjerning, Pernille Hansen, Rikke Nørregaard, Boye Lagerbon Jensen, Grith Lykke Sørensen, Ole Skøtt · 2003 · Circulation Research
98. The Incidence of Ischemic Stroke in Chronic Heart Failure: A Meta-Analysis
    Brandi J. Witt, Apoor Suresh Gami, Karla V. Ballman, Robert D. Brown, Ryan A. Meverden, Stephen J. Jacobsen, Veronique Lee Roger · 2007 · Journal of Cardiac Failure
99. Serum Cortisol as a Useful Predictor of Cardiac Events in Patients With Chronic Heart Failure
    Masayuki Yamaji, Takayoshi Tsutamoto, Chiho Kawahara, Keizo Nishiyama, Takashi Yamamoto, Masanori Fujii, Minoru Horie · 2009 · Circulation Heart Failure
100. Statin Use and Survival Outcomes in Elderly Patients With Heart Failure
     Joel Geoffrey Ray, Yanyan Gong, Kathy Sykora, Jack V. Tu · 2005 · Archives of Internal Medicine